Epigenetics Market

Epigenetics Market worth $1.6 billion by 2022

The Epigenetics Market was valued at USD 854 million in 2017 and is estimated to grow at a CAGR of 13.5% during the forecast period, to reach USD 1.6 billion by 2022. The growth in this market is mainly due to declining sequencing costs, increasing research activities, the availability of funding for epigenetics research, and growing cancer prevalence.

Browse 191 market data Tables and 37 Figures spread through 230 Pages and in-depth TOC on "Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022"

View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html

Kits formed the largest product segment in the epigenetics market in 2016 

Based on product, the epigenetics market is segmented into enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. In 2016, kits accounted for the largest share of this market mainly because a large number of kits are used in various epigenetics techniques. Currently, several companies are providing easy-to-use kits for studying epigenetic processes such as DNA methylation and histone modifications. The growing prevalence of several diseases and the increasing number of R&D activities in epigenetics and genomics are leading to an increase in the use of kit-based products.

The metabolic diseases segment accounted for the largest share of the epigenetics market, by application, in 2016 

Based on application, the epigenetics market is segmented into oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications. During the forecast period, the metabolic diseases application segment is estimated to grow at the highest CAGR owing to the significant increase in the prevalence of metabolic diseases such as diabetes and obesity. Due to the high burden of these health conditions on healthcare systems across the globe, several research studies and funding initiatives are focusing on developing new and effective drugs for their treatment.

North America dominated the global epigenetics market in 2017 

North America accounted for the largest share of the epigenetics market in 2016, followed by Europe. Most of the key players in the global epigenetics market are based in North America. The US is a major market for epigenetics in North America and is currently witnessing an increase in the number of research activities in the field of epigenetics as well as a favorable government funding scenario for epigenetics research.

The major players in this market are Illumina (US), Thermo Fisher Scientific (US), Diagenode (Belgium), QIAGEN (US), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-Rad (US).

Don’t miss out on business opportunities in NRemote Towers Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
BT 2775
PR Published ON
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Epigenetics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2022 MarketsandMarkets Research Private Ltd. All rights reserved

Digital Virtual Assistant - MarketsandMarkets